KIM II / Hämatologie und Internistische Onkologie / Forschung / Studienzentrale / Aktuell laufende Studien / Tumoren der Lunge
Tumoren der Lunge
|
GSK213824 |
Phase II |
A Phase 2, Randomized, Open-label Platform Study Utilizing a Master Protocol to Evaluate Novel Immunotherapy Combinations in Participants with Previously Untreated Locally Advanced/Metastatic Programmed Death Ligand 1-High Non‑Small‑Cell Lung Cancer |
|
HARMONi-3 SMT112-3003 |
Phase III |
Clinical Study of Ivonescimab for First-line Treatment of Metastatic Squamous NSCLC Patients |